AGM/EGM19 Sept 2026, 12:00 pm
Nectar Lifesciences Ltd. Files Revised AGM Proceedings
AI Summary
Nectar Lifesciences Ltd. has filed revised proceedings of its 31st Annual General Meeting (AGM) held on September 18, 2026. The meeting was conducted via Video Conferencing (VC)/Other Audio Visual Means (OAVM) in compliance with MCA and SEBI circulars. The statutory auditors and secretarial auditors expressed unqualified opinions for the financial year 2025-2026, with no adverse comments on the financial statements. The company also detailed the remote e-voting and e-voting at the AGM process facilitated by KFin Technologies Limited.
Key Highlights
- Revised proceedings of the 31st AGM filed.
- AGM conducted via VC/OAVM as per regulatory guidelines.
- Statutory and secretarial auditors provided unqualified opinions.
- No adverse comments on financial statements for FY 2025-2026.
- Details on e-voting process and service provider KFin provided.
Price Impact
More from NECLIFE